Biography: Life Sciences

Lori Cohen is a partner with Greenberg Traurig LLP, an international law firm with 1,800 attorneys, including over 600 litigators. She is the chair of Greenberg Traurig's pharmaceutical, medical device and health care litigation practice group of more than 90 attorneys. She has a national litigation practice focusing on product liability litigation and specifically, medical device and pharmaceutical litigation. Lori is national counsel for a medical device manufacturer handling its litigation including class actions and a multidistrict litigation. She has served as both national counsel and regional counsel for pharmaceutical and medical device companies and has expertise in mass tort, multidistrict and class action litigation. She also has vast experience in other products liability litigation and jury trials of all kinds. Lori has defended numerous health care providers, including physicians, hospitals and managed care entities nationwide.

Lori has tried 55 cases, all to defence verdicts. During the past four years, she obtained defence verdicts as a result of a three-month, alleged $78 million-dollar trial against the world's leading manufacturer of pacemakers; a four-week, alleged $20 million-dollar trial involving an implantable neurostimulation device; a four-week, alleged US$18 million-dollar trial involving three consolidated cases against the manufacturer of a continuous local anesthesia infusion drug pump; a three-week medical malpractice trial in which she represented OB/GYN clients; and a three-week medical malpractice trial for a hospital involving allegations of an overdose on a patient controlled analgesia (PCA) pump.

Lori has been featured in The National Law Journal's "Winning - Successful Strategies From Some of the Nation's Top Litigators,' a special report recognising 10 attorneys from across the U.S. She has been recognised by The National Law Journal as one of 'The 50 Most Influential Women Lawyers in America.' The National Law Journal has recognized two of her defence trial victories as 'Top Defense Wins' in recent years, and she has been featured in The National Law Journal's "Top 40 Under 40," which highlights the 40 most successful litigators under the age of 40 in the country. She is listed in Best Lawyers in America, The Legal 500: United States, Outstanding Lawyers in America, Chambers & Partners USA Guide, The International Who's Who of Business Lawyers, The International Who's Who of Life Sciences Lawyers, The International Who's Who of Product Liability Defence Lawyers, Georgia Trend's Legal Elite and Georgia Super Lawyers, including Top 100 Georgia Super Lawyers and Top 50 Female Georgia Super Lawyers for 2005-2011. Lori was one of only nine attorneys and one of only three female attorneys included in the 2010 and 2011 editions of Chambers & Partners USA Guide's national pharmaceutical industry products liability table.

Biography: Product Liability Defence

Lori Cohen is a partner with Greenberg Traurig, LLP, an international law firm with 1,800 attorneys, including over 600 litigators. She is the chair of Greenberg Traurig's pharmaceutical, medical device and healthcare litigation practice group of more than 90 attorneys. She has a national litigation practice focusing on product liability litigation and specifically, medical device and pharmaceutical litigation. Lori is national counsel for a medical device manufacturer handling its litigation including class actions and a multidistrict litigation. She has served as both national counsel and regional counsel for pharmaceutical and medical device companies and has expertise in mass tort, multidistrict and class action litigation. She also has vast experience in other products liability litigation and jury trials of all kinds. Lori has defended numerous healthcare providers, including physicians, hospitals and managed care entities nationwide.

Lori has tried 55 cases, all to defence verdicts. During the past four years, she obtained defence verdicts as a result of a three-month, alleged $78 million dollar trial against the world's leading manufacturer of pacemakers; a four-week, alleged $20 million dollar trial involving an implantable neurostimulation device; a four-week, alleged $18 million dollar trial involving three consolidated cases against the manufacturer of a continuous local anesthesia infusion drug pump; a three-week, medical malpractice trial in which she represented OB/GYN clients; and a three-week medical malpractice trial for a hospital involving allegations of an overdose on a patient controlled analgesia (PCA) pump.

Lori has been featured in The National Law Journal's "Winning - Successful Strategies From Some of the Nation's Top Litigators,' a special report recognising ten attorneys from across the US. She has been recognised by The National Law Journal as one of 'The 50 Most Influential Women Lawyers in America'. The National Law Journal has recognised two of her defense trial victories as 'Top Defense Wins' in recent years, and she has been featured in The National Law Journal's "Top 40 Under 40," which highlights the 40 most successful litigators under the age of 40 in the country. She is listed in Best Lawyers in America, The Legal 500: United States, Outstanding Lawyers in America, Chambers & Partners USA Guide, The International Who's Who of Business Lawyers, The International Who's Who of Life Science Lawyers, The International Who's Who of Product Liability Defence Lawyers, Georgia Trend's Legal Elite and Georgia Super Lawyers, including Top 100 Georgia Super Lawyers and Top 50 Female Georgia Super Lawyers for 2005-2011. Lori was one of only nine attorneys and one of only three female attorneys included in the 2010 and 2011 editions of Chambers & Partners USA Guide's national Pharmaceutical Industry Products Liability Table.

Lori is active in national organisations in her specialty, including the International Association of Defense Counsel, the Product Liability Advisory Council, the Defense Research Institute and the American Bar Association. She is also an editor for three national publications (Medical Malpractice Law and Strategy, Product Liability Law and Strategy and Pharmaceutical and Medical Device Law Bulletin) and has authored numerous articles in the areas of products liability, medical malpractice, medical device and pharmaceutical litigation. She received her BA, cum laude, in 1987 from Duke University and her JD, with distinction, in 1990 from Emory University School of Law.